The Valley Desk

NCT02096263 · Interventional trial

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Overall registry status Completed

Phase 3

Conditions Acellular Pertussis, Diphtheria, Haemophilus Influenzae Type b, Hepatitis B, Poliomyelitis, Tetanus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov